Durolane
PMA P170007
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR PMA | NumberP170007 | Date29 Aug 2017 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
Official records
- EUDAMED public site
- FDA PMA database P170007
From the FDA record
FDA PMA P170007
- Received by the FDA
- 2 Mar 2017
- FDA decision
- 29 Aug 2017
- FDA review time
- 180 days from receipt to decision
- Docket number
- 17M-5438
APPROVAL FOR DUROLANE. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGICAL THERAPY OR SIMPLE ANALGESICS, E.G., ACETAMINOPHEN.
Across registries
- FDA PMA P170007 decided 29 Aug 2017 Active
- EUDAMED Active
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Generic name
- Acid, hyaluronic, intraarticular
- FDA applicant
- Bioventus, LLC
- PMA number
- FDA product code
- MOZ
- Device class
- Class III
- Advisory committee
- Orthopedic
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
Durolane is a hyaluronic acid intraarticular injection designed for the treatment of pain associated with osteoarthritis of the knee. It is indicated for use in patients who have not responded adequately to conservative non-pharmacological therapy or simple analgesics such as acetaminophen.
This device is manufactured by Bioventus LLC and has received FDA PMA approval. It is intended for clinical application in patients meeting the specified criteria for osteoarthritis pain management.
Devices cleared under P170007
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Durolane | N/A | 05065026658005 | — | On the market |
| Durolane | N/A | 05060548950071 | — | On the market |
| DUROLANE 1082020 | 1082020 | 08437027710001 | — | On the market |
| DUROLANE 1082020 | 1082020 / 1082020 | 00816986020808 | — | On the market |
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Orthovisc High Molecular Weight Hyaluronan by Anika Therapeutics, Inc.
- Hyalgan Acid, Hyaluronic, Intraarticular by Fidia Farmaceutici S.p.A.
- Euflexxa (1% Sodium Hyaluronate) by Ferring Pharmaceuticals, Inc.
- Gel-Syn Acid, Hyaluronic, Intraarticular by Ibsa Institut Biochimique SA
- Monovisc Injectable Intra-Articular Device by Anika Therapeutics, Inc.
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.